US Stocks
/
Estrella Immunopharma, Inc. Share Price

Estrella Immunopharma, Inc. Share Price

NASDAQ: ESLA | Micro Cap
$0.51
-$0.03 (-5.8%) Last updated on 19 Sep, 2026 | 00:53 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Estrella Immunopharma, Inc. Stock Performance

Open
$0.55
Prev. Close
$0.54
Circuit Range
N/A
Day Range
$0.55 - $0.55
Year Range
$0.54 - $3.08
Volume
192
Average Traded
$0.55

Estrella Immunopharma, Inc. Share Price Today

As of 20 September 2026, Estrella Immunopharma, Inc.'s share price is $0.51. The stock opened at $0.55, compared to its previous close of $0.54. During today's trading session, Estrella Immunopharma, Inc.'s share price traded between $0.55 and $0.55, with an average price of $0.55. Over the past 52 weeks, the stock has recorded a high of $3.08 and a low of $0.54. In terms of performance, Estrella Immunopharma, Inc.'s share price has declined by 50.97% over the last six months and is down 57.15% on a year-on-year basis.

Estrella Immunopharma, Inc. Share Price Chart

$0.55$0.55
L
Show Current Price
H

Estrella Immunopharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$18.77M
PE Ratio (TTM)
-1.46
Dividend Yield
N/A
EPS (TTM)
$-0.35
Revenue (TTM)
N/A
Return On Equity (TTM)
126.02%
Profit Margin
N/A
Debt to Equity
-1.31
Quarterly Earnings Growth YoY
-42.18%

Estrella Immunopharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$1.02M-$469530.00-$3.38M-$2.10M-$5.54M-$4.80M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A54.00%-619.17%37.68%-163.50%13.41%

Estrella Immunopharma, Inc. Annual Profit & Loss

All figures in USD

Particulars202120222025
RevenueN/AN/AN/A
Net Profit-$1.52-$996104.00-$13.06M
Net Profit MarginN/AN/AN/A
Income ChangeN/A-65533057.89%-1211.46%

About Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.

Estrella Immunopharma, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$0.70
$0.55
-25.03%
Aug 2026
$0.74
$0.74
-0.14%
Jul 2026
$0.95
$0.74
-24.87%
Jun 2026
$1.11
$0.98
-12.05%
May 2026
$1.67
$1.12
-31.08%
Apr 2026
$1.02
$1.63
+56.25%
Mar 2026
$1.10
$1.04
-14.05%
Feb 2026
$1.13
$1.21
+8.04%
Jan 2026
$1.48
$1.12
-27.27%
Dec 2025
$2.05
$1.54
-27.36%
Nov 2025
$2.46
$2.12
-11.48%
Oct 2025
$1.47
$2.40
+101.26%

ESLA Share Price FAQs

What is Estrella Immunopharma, Inc. share price today?

chevron-up
Estrella Immunopharma, Inc. share price today is $0.51 as on September 19, 2026 at 12:53 am IST.

What is the 52 week high and 52 week low of Estrella Immunopharma, Inc. stock?

chevron-up
The 52 week high of Estrella Immunopharma, Inc. stock is $3.08, while the 52 week low is $0.54 as of 19 Sep '26.

What is ESLA's market capitalisation today?

chevron-up
ESLA market capitalisation is $18.77M as of September 20, 2026, at 4:37 pm IST.

What is ESLA's net income for the last quarter?

chevron-up
ESLA's net income for the last quarter is -0.00B USD.

What is the 5 year returns of ESLA?

chevron-up
The 5 year returns of ESLA is -94.85% as on 19 Sep '26.

What is the high & low stock price of ESLA today?

chevron-up
ESLA stock price hit a high of $0.55 and low of $0.55 as of 19 Sep '26.

Can I buy ESLA shares in India?

chevron-up
Yes. You can buy ESLA in India by opening an international trading account.